RT @BrainTumorInst: MGMT methylation scores may identify low-grade glioma patients who benefit from first-line temozolomide, according to n…
MGMT methylation scores may identify low-grade glioma patients who benefit from first-line temozolomide, according to new research from an international team including @roger_stupp: https://t.co/vXaUVc3Z3O https://t.co/R8bBLqCy0m
RT @BrainTumorInst: In Acta Neuropathologica, an international team including @roger_stupp examines the DNA methylome of DNA damage respons…
RT @BrainTumorInst: In Acta Neuropathologica, an international team including @roger_stupp examines the DNA methylome of DNA damage respons…
RT @BrainTumorInst: In Acta Neuropathologica, an international team including @roger_stupp examines the DNA methylome of DNA damage respons…
RT @BrainTumorInst: In Acta Neuropathologica, an international team including @roger_stupp examines the DNA methylome of DNA damage respons…
In Acta Neuropathologica, an international team including @roger_stupp examines the DNA methylome of DNA damage response genes and benefit from radiotherapy or temozolomide in IDH mutant low-grade glioma: https://t.co/vXaUVc3Z3O https://t.co/BoXzJomhwZ
RT @ActaNeuropathol: In low-grade diffuse gliomas, CpG methylation of four DNA damage response genes (MGMT, MLH3, RAD21, and SMC4) predicts…
RT @ActaNeuropathol: In low-grade diffuse gliomas, CpG methylation of four DNA damage response genes (MGMT, MLH3, RAD21, and SMC4) predicts…
PubMed: The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033. https://t.co/5EPbMJCAum
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033. https://t.co/tw5d7WtFsR
#newupdatesneuroonc #braintumours #neuroonc The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033. - https://t.co/ZqbOGeWjK0